New York City Childrens Center Queens Mid Childhood Clinic at PS 169

New York City Childrens Center Queens Mid Childhood Clinic at PS 169 (Kansas City, MO) is a SAMHSA Behavioral Health Treatment Services Locator-registered facility. The facility offers specific levels of care: Inpatient, Outpatient. Evaluation of this facility against current clinical standards should encompass ASAM 4e framework alignment, MAT policy, and payer-specific network status.

Care levels at New York City Childrens Center Queens Mid Childhood Clinic at PS 169

Level-of-care documentation: The facility's documented care levels are The facility offers specific levels of care: Inpatient, Outpatient. — each of which is appropriate for specific clinical presentations. Matching the level to the specific clinical need is the pre-admission work. Under MHPAEA 2024 medical-necessity criteria disclosure, plan-specific criteria for each of these levels must be available to patients upon request. Mismatch between documented clinical need and offered level of care is a common source of authorization denial.

Insurance and payment

New York City Childrens Center Queens Mid Childhood Clinic at PS 169 accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The operational prerequisite for admission is written documentation of: (a) network contract status; (b) prior authorization; (c) cost-sharing structure; (d) medical-necessity criteria applied. Absence of any of these four increases the probability of post-admission financial disagreement.

Specialty programming

The facility's documented specialty programming includes: Young adults, Seniors or older adults, Clients who have experienced trauma. Specialty-program verification requires review of: (a) dedicated specialty-track programming hours per week; (b) specialty-credentialed clinical staffing (e.g., LCSW with trauma specialization, perinatal-nurse certification, adolescent-development training); (c) specialty-specific clinical assessment protocols; (d) specialty-specific outcome measurement. Marketing designation alone is insufficient for clinical confidence.

Before you call

Pre-admission due-diligence for New York City Childrens Center Queens Mid Childhood Clinic at PS 169: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via MO behavioral-health regulator inspection records. If the clinical situation involves opioid use disorder, confirm explicitly whether New York City Childrens Center Queens Mid Childhood Clinic at PS 169 offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.